Albogen Cimetidine Tablet 200 Milligrams

Adult dose

As cimetidine, administer 400 mg orally twice a day (morning and at bedtime) or 800 mg once daily (at bedtime). In addition, 300 mg can be taken orally four times a day (after meals and at bedtime). It can be increased to a total of 1.6 g (400 mg four times daily (after meals and at bedtime)). For acute gastritis and acute exacerbation of chronic gastritis, take 200 mg twice a day or 400 mg once a day.

Child dose

Administer 20-40 mg per kg of body weight, divided into oral doses daily.

This medication contains the ingredient cimetidine and should not be used by patients with specific allergic reactions or those taking another medication called dofetilide. Patients with lactose intolerance or genetic lactose metabolism disorders should also avoid this medication. Patients with kidney or liver function problems, those with a history of drug allergies, the elderly, children, and those undergoing hemodialysis should use this medication cautiously. This medication may hide symptoms of gastric cancer, so it should only be used after confirming malignancy, and patients with Helicobacter pylori infection require eradication treatment. Patients allergic to Yellow No. 4 (tartrazine) should also be careful. Rarely, adverse symptoms such as decreased blood cell counts, liver function abnormalities, kidney dysfunction, allergic reactions, gynecomastia, gastrointestinal symptoms, neurological symptoms, etc., may occur, and if any unusual symptoms arise, immediate consultation with a doctor is needed. The minimum effective dose should be used, and if ineffective, it is best to switch to another treatment method. The risk of pneumonia may increase in the elderly or those with chronic diseases, so caution is advised. It may interact with other drugs, so especially when combined with anticoagulants, antidepressants, antiarrhythmics, calcium channel blockers, antifungal agents, etc., follow the doctor's instructions. Women who are pregnant or breastfeeding should use this medication cautiously as its safety has not been established, and breastfeeding should be discontinued during its use. Overdose may lead to severe symptoms such as respiratory depression, and immediate medical attention should be sought, and intravenous administration should be given slowly to minimize side effects. This medication should be kept out of reach of children and should not be transferred to other containers for safety.

Serious side effects

Systemic fatigue, weakness, subcutaneous hemorrhage, mucosal hemorrhage, fever, jaundice, initial symptom fever, breathing difficulties, shock, anaphylaxis-like reactions, rash, consciousness disturbances, convulsions, Stevens-Johnson syndrome, toxic epidermal necrolysis, epidermal necrosis, erythema multiforme, exfoliative dermatitis, exfoliative erythema, systemic erythema, respiratory distress, abnormal blood tests, bleeding symptoms due to thrombocytopenia

Mild side effects

• Leukopenia
• granulocytopenia
• agranulocytosis
• thrombocytopenia
• pancytopenia
• aplastic anemia
• immune hemolytic anemia
• hepatitis
• elevated AST and ALT
• liver function abnormalities

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius. By doing so, the effectiveness of the medication can be preserved for a longer period.

Appearance

Pale yellow round film-coated tablet

Package unit

300 tablets/bottle